The trials and tribulations of pediatric drug trials.
Shinnar
Shlomo
S
Pellock
John M
JM
D000367:Age Factors; D000927:Anticonvulsants / Q000008:administration & dosage* / Q000009:adverse effects* / Q000493:pharmacokinetics; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D002648:Child; D002986:Clinical Trials as Topic / Q000592:standards*; D064420:Drug-Related Side Effects and Adverse Reactions; D004827:Epilepsy / Q000188:drug therapy*; D006801:Humans; D008991:Monitoring, Physiologic / Q000592:standards / Q000639:trends; D000078330:Oxcarbazepine; D010372:Pediatrics / Q000592:standards*; D010601:Pharmacology, Clinical / Q000592:standards*; D015983:Selection Bias
D000927:Anticonvulsants; D002220:Carbamazepine; D000078330:Oxcarbazepine